Nasdaq: RTSN
Retension Pharmaceuticals insiders
The officers, directors and 10% owners of Retension Pharmaceuticals, Inc. who hold the most stock, valued at the live RTSN price.
$13.01
RTSN today −$880K (−6.34%)
Market closed. Prices as of Nov 19, 4:04 PM ET
- Ranked insiders
- 2
- Their RTSN stock
- $11.4M
- Market value
- $108M
- Held by ranked insiders
- 10.5%
Insiders by value of RTSN holdings
SEC ownership page| # | Insider | Role | Shares | Value | Of company | Overall rank |
|---|---|---|---|---|---|---|
| 1 | Eric L. Keller | CHIEF EXECUTIVE OFFICER | 464,407 | $6.0M | 5.57% | 12712th |
| 2 | Paul Sweetnam | CHIEF SCIENTIFIC OFFICER | 409,243 | $5.3M | 4.91% | 13847th |
Only insiders worth at least $5 million in listed stock are ranked. Holdings come from each insider's latest Form 3, 4 or 5 for Retension Pharmaceuticals; see each profile for the filing.